Geralla, Chummy N.

HRN: 27-21-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2025
07/16/2025
IV
500mg
Q8
G1P0 Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines